How was tesamorelin given in the trials?
Researchers used shots under the skin. Here are the people, time, and amounts. This isn’t a guide for your care.
What does tesamorelin dosage mean here?
Drug makers changed a natural growth message so it would last longer. Trial teams then looked for one shot that worked all day. Most chose 2 mg under the skin [1][7]. A few teams tested 1 mg.
The drug leaves the blood in about half an hour [16]. Its effect on the body lasts longer. That difference shaped the daily trial plan.
This page reports what those teams gave. It doesn’t tell you what to take. Large studies support one narrow HIV use.
Other uses don’t have the same proof. A doctor can judge how that limit fits your care. You can use these facts to ask a clear question.
Which tesamorelin amounts did the trials use?
Most large trials used 2 mg under the skin. Both main Phase 3 trials used that amount [1][2]. It is also the approved amount. The trial with four hundred twelve people used it daily.
The 52-week study did the same. So did the joined check of eight hundred six people. The liver-fat trial again used 2 mg daily [1][2][7][3].
That steady amount makes the findings easier to compare. The 2 mg amount didn’t keep changing. At 2 mg, you can line up one study with another.
Some smaller studies tested 1 mg under the skin. One studied memory in older adults. Another studied blood sugar in type-two diabetes [4].
The better-known trial amount remained 2 mg daily. A later tesamorelin form is more concentrated. That means less liquid holds the dose. It doesn’t mean the drug amount is larger.
That later form adds no new proof of benefit. No study here tested far more than 2 mg. A larger effect therefore isn’t known. More drug may not mean more help.
The papers can’t answer that question. They show only what the trial teams chose. Keep that limit in mind when you see larger amounts claimed.
How long did people stay in the studies?
At 26 weeks, the main trial checked fat stored near the organs [1][2]. A longer part ran 52 weeks. The liver-fat study ran 6 months [3]. A small study in healthy men ran 2 weeks [4].
Five trials went into a joint 2026 review [13]. Fat loss showed by the 26-week check. It held for a year while the shots continued [2]. The studies didn’t show what happens over many years.
Who took part matters just as much. All main fat-loss trials enrolled adults with HIV [1][2][7]. Those adults were taking HIV drugs.
One small non-HIV study checked body signals [4]. Another studied memory in older adults. Neither gives a broad dosing guide for you.
Where did the trial teams give the shot?
The human trials used a shot under belly skin [1]. That is also the approved way to give it. The studies didn’t test a pill or nose spray. The peptide would break apart if swallowed.
The needle went into belly skin. The drug didn’t work only under that spot. It traveled to a small gland under the brain [4].
The gland sent its own hormone through the body. That’s how the effect reached fat around the organs. The needle site and the target weren’t the same place.
Why did IGF-1 last after one daily shot?
A study described fast drug removal as 1,060 liters an hour. That figure doesn’t mean blood leaves the body. It estimates how quickly the body clears tesamorelin.
By day 14, the body took in 13% more from each shot than on day 1 [16]. The study didn’t call that change better or worse. Drug guides say half is gone in 26 to 38 minutes.
The body’s answer lasts past those minutes. IGF-1, the liver growth signal, stays up between shots [16]. Trial teams used one shot each day.
The drug and its effect don’t end together. That difference explains the daily trial plan. Blood timing alone can mislead you.
Why doesn’t tesamorelin break down at once?
Researchers changed one end of the peptide, its short protein chain. A body substance normally breaks down the natural message. The change slows that work [8]. Tesamorelin still leaves blood fast.
The approved medicine starts as powder. Its label names the mixing liquid and calls for cold storage.
Powder sold online for lab research has no approval as a drug for people [15]. It may not have the same strength or purity. That difference matters when you weigh safety claims.